These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12520782)
1. [Use of dopamine analogs in Parkinson's disease treatment]. Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(12):53-5. PubMed ID: 12520782 [No Abstract] [Full Text] [Related]
2. [Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study]. Fedorova NV Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(11):21-4. PubMed ID: 14681961 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of Parkinson's disease: use of piribedil]. Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):54-6. PubMed ID: 14870695 [No Abstract] [Full Text] [Related]
4. Piribedil--an oral dopamine agonist for treatment of Parkinson's disease. Sweet RD; Wasterlain C; McDowell FH Trans Am Neurol Assoc; 1974; 99():258-60. PubMed ID: 4463553 [No Abstract] [Full Text] [Related]
5. [The effectiveness and tolerance of piribedil as adjunct therapy to levodopa in patients with Parkinson's disease: a nine month follow up]. Salazar Tortolero G; Wix Ramos R; Salazar Aladrén P; Jiménez León JC Rev Neurol; 2004 Apr 16-30; 38(8):715-9. PubMed ID: 15122540 [TBL] [Abstract][Full Text] [Related]
13. Piribedil (ET 495) in the treatment of Parkinson's disease combined with amantadine or levodopa. Callaghan N; Fitzpatrick E; O'Mahony JB Acta Neurol Scand; 1975 Sep; 52(3):179-86. PubMed ID: 1098359 [TBL] [Abstract][Full Text] [Related]
14. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. Klivényi P; Vécsei L Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097 [TBL] [Abstract][Full Text] [Related]
15. Piribedil: its synergistic effect in multidrug regimens for parkinsonism. Feigenson JS; Sweet RD; McDowell FH Neurology; 1976 May; 26(5):430-3. PubMed ID: 944394 [TBL] [Abstract][Full Text] [Related]
16. High concentration of plasma methoxytyramine: dopamine-producing tumour or Parkinson's disease therapy? Chtioui H; Sadowski SM; Winzeler B; Tschopp O; Grouzmann E; Abid K Ann Clin Biochem; 2019 Jul; 56(4):466-471. PubMed ID: 30974961 [No Abstract] [Full Text] [Related]
17. Dopaminergic agonist effects on Parkinsonian clinical features and brain monamine metabolism. Rinne UK; Sonninen V; Marttila R Adv Neurol; 1975; 9():383-92. PubMed ID: 1096575 [TBL] [Abstract][Full Text] [Related]
18. [Piribedil in the treatment of Parkinson disease (author's transl)]. Nardini M; Sciannandrone R; Fieschi C; De Simone G Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998 [TBL] [Abstract][Full Text] [Related]
19. [The concept of continuous dopaminergic stimulation in the treatment of late stages of Parkinson's disease]. Titova NV; Katunina EA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(12):105-12. PubMed ID: 24596973 [No Abstract] [Full Text] [Related]
20. Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems. Carlsson A J Neural Transm (Vienna); 2002 May; 109(5-6):777-87. PubMed ID: 12111467 [No Abstract] [Full Text] [Related] [Next] [New Search]